Figure 1.
Design of an antibody–drug conjugate and recommended biological properties. Characteristic of antigen, antibody, linker–antibody attachment, linker, linker–payload attachment and payload are detailed. The antibody Fc part is implied in half-life and immunogenicity. The Fab part controls affinity and avidity to the targeted antigen.
